Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyLindsey R. Baden, Zeenat Diwan, Sankar Swaminathan et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 65
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy RecipientsAlpana Waghmare, Zainab Shahid, Maheen Z. Abidi et al.|Biology of Blood and Marrow Transplantation|2020Cited by 65
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular TherapySteven A. Pergam, Paul A. Carpenter, Joshua A. Hill et al.|Biology of Blood and Marrow Transplantation|2019Cited by 40
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Matthew Greenwood, Jad Othman et al.|Transplant Infectious Disease|2020Cited by 16
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell TransplantationJulian Lindsay, Monica A. Slavin, Jad Othman et al.|Open Forum Infectious Diseases|2021Cited by 15